Buechter K J, Arnold M, Steele B, Martin L, Byers P, Gomez G, Zeppa R, Augenstein J
Department of Surgery, University of Miami School of Medicine, Florida.
Am Surg. 1990 Apr;56(4):204-8.
In order to determine the usefulness of serum amylase and lipase in the initial evaluation and subsequent management of blunt abdominal trauma (BAT) patients, we collected serum amylase and lipase on 85 consecutive BAT patients at admission, hospital day 1, hospital day 3, and hospital day 7. Only one patient had a pancreatic injury. A total of 45 patients (53%) had at least one enzyme abnormality during the study. There was no correlation between amylase or lipase values and age, sex, type of injury, diagnostic tests, operation, and outcome. In a control group of nonabdominal-trauma patients with admit studies only, all enzyme values were normal. We conclude that serum amylase and lipase are randomly elevated in patients with nonpancreatic-BAT both initially and during subsequent hospitalization and are not useful clinical tools in these patients.
为了确定血清淀粉酶和脂肪酶在钝性腹部创伤（BAT）患者初始评估及后续治疗中的作用，我们收集了85例连续收治的BAT患者入院时、住院第1天、住院第3天和住院第7天的血清淀粉酶和脂肪酶数据。仅1例患者有胰腺损伤。在研究期间，共有45例患者（53%）至少有一项酶异常。淀粉酶或脂肪酶值与年龄、性别、损伤类型、诊断检查、手术及结局之间无相关性。在仅进行入院检查的非腹部创伤患者对照组中，所有酶值均正常。我们得出结论，非胰腺性BAT患者在初始及后续住院期间血清淀粉酶和脂肪酶随机升高，对这些患者而言并非有用的临床工具。
